Literature DB >> 3372541

Gene expression in mineralizing chick epiphyseal cartilage.

P S Leboy1, I M Shapiro, B D Uschmann, O Oshima, D Lin.   

Abstract

To map transcriptional events associated with mineralization in developing long bones, we have established protocols for preparing RNA from regions of chick epiphyseal cartilage. Using these RNA preparations, we have probed for appearance of mRNA coding for type I, II, and X collagen, as well as osteonectin and calmodulin. Type II collagen mRNA was found in proliferating cartilage and, in lower amounts, in hypertrophic/calcifying cartilage. Type X mRNA was absent from proliferating cartilage and present in hypertrophic/calcifying cartilage at steady state levels slightly lower than that of type II mRNA. Type I mRNA was the major collagen mRNA species in endochondral bone; however, significant amounts of type X mRNA were also found. Examination of type X/type II ratios suggest that the cells producing type X mRNA in bone are different from those in the hypertrophic/calcifying cartilage region. Osteonectin mRNA was present in endochondral bone; however, significant amounts were also detected in precalcified cartilage. Indeed, the level of osteonectin mRNA was significantly higher in the resting/proliferating region than in the hypertrophic/calcifying region of the cartilage. No correlation was observed between calmodulin mRNA and the development of mineralization; levels of this message were slightly lower in endochondral bone, embryonic sterna, and calvaria than they were in chick liver and considerably lower than the calmodulin mRNA levels in chick brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372541

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro.

Authors:  Ronald R Gomes; Mary C Farach Carson; Daniel D Carson
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

2.  The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen.

Authors:  M Alini; Y Matsui; G R Dodge; A R Poole
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

3.  Coordinate inhibition of alkaline phosphatase and type X collagen syntheses by 1,25-dihydroxyvitamin D3 in primary cultured hypertrophic chondrocytes.

Authors:  S Inao; H E Conrad
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

4.  The development of articular cartilage: I. The spatial and temporal patterns of collagen types.

Authors:  E H Morrison; M W Ferguson; M T Bayliss; C W Archer
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

5.  Development and characterization of Xl1, a Xenopus laevis chondrocyte-like cell culture.

Authors:  Natércia Conceição; Michael Viegas; João Fidalgo; M Leonor Cancela
Journal:  Mol Cell Biochem       Date:  2012-10-10       Impact factor: 3.396

6.  Developmental expression of genes in chick growth cartilage detected by in situ hybridization.

Authors:  O Oshima; P S Leboy; S A McDonald; R S Tuan; I M Shapiro
Journal:  Calcif Tissue Int       Date:  1989-09       Impact factor: 4.333

7.  Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage.

Authors:  M Pacifici; O Oshima; L W Fisher; M F Young; I M Shapiro; P S Leboy
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

8.  Modulation of aggrecan and link-protein synthesis in articular cartilage.

Authors:  A J Curtis; R J Devenish; C J Handley
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

9.  Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Applications to musculoskeletal tissues.

Authors:  I D Crabb; S S Hughes; D G Hicks; J E Puzas; G J Tsao; R N Rosier
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

10.  Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes.

Authors:  M Enomoto-Iwamoto; M Iwamoto; Y Mukudai; Y Kawakami; T Nohno; Y Higuchi; S Takemoto; H Ohuchi; S Noji; K Kurisu
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.